Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 141 | BLTE | BELITE BIO INC | Healthcare | 1,929.0 | $308K | 0.09% | +47.0 | +2.5% | $159.44 | -10.9% |
| 142 | CTMX | CYTOMX THERAPEUTICS INC. | Healthcare | 65,080.0 | $306K | 0.08% | +2K | +2.5% | $4.70 | -21.5% |
| 143 | IMNM | IMMUNOME INC | Healthcare | 13,932.0 | $305K | 0.08% | +339.0 | +2.5% | $21.87 | +0.2% |
| 144 | ANNX | ANNEXON INC | Healthcare | 54,866.0 | $304K | 0.08% | +1K | +2.5% | $5.54 | -0.4% |
| 145 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 2,860.0 | $301K | 0.08% | +70.0 | +2.5% | $105.40 | -5.1% |
| 146 | — | APOGEE THERAPEUTICS INC | — | 3,538.0 | $298K | 0.08% | +87.0 | +2.5% | $84.17 | — |
| 147 | CELC | CELCUITY INC | Healthcare | 2,589.0 | $296K | 0.08% | +61.0 | +2.4% | $114.14 | +17.6% |
| 148 | SMMT | SUMMIT THERAPEUTICS INC | Healthcare | 15,519.0 | $294K | 0.08% | +378.0 | +2.5% | $18.96 | -10.3% |
| 149 | GHRS | GH RESEARCH PLC | Healthcare | 20,920.0 | $294K | 0.08% | +512.0 | +2.5% | $14.06 | +64.7% |
| 150 | BCAX | BICARA THERAPEUTICS INC | Healthcare | 14,755.0 | $293K | 0.08% | +360.0 | +2.5% | $19.89 | +10.5% |
| 151 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 15,166.0 | $291K | 0.08% | +371.0 | +2.5% | $19.20 | +0.9% |
| 152 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 20,815.0 | $289K | 0.08% | +508.0 | +2.5% | $13.90 | -1.6% |
| 153 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 80,438.0 | $288K | 0.08% | +2K | +2.5% | $3.58 | -16.2% |
| 154 | PGEN | PRECIGEN INC | Healthcare | 73,899.0 | $286K | 0.08% | +2K | +2.5% | $3.87 | +9.6% |
| 155 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 5,816.0 | $286K | 0.08% | +140.0 | +2.5% | $49.16 | +4.8% |
| 156 | OMER | OMEROS CORP | Healthcare | 26,865.0 | $284K | 0.08% | +653.0 | +2.5% | $10.56 | +10.3% |
| 157 | CYTK | CYTOKINETICS INC | Healthcare | 4,303.0 | $284K | 0.08% | +56.0 | +1.3% | $65.91 | +15.7% |
| 158 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 9,007.0 | $282K | 0.08% | +218.0 | +2.5% | $31.29 | +26.9% |
| 159 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 52,846.0 | $280K | 0.08% | +1K | +2.5% | $5.29 | -58.4% |
| 160 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 16,718.0 | $275K | 0.08% | +408.0 | +2.5% | $16.45 | +16.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
30.6%
Financial Services
23.4%
Industrials
11.2%
Technology
10.7%
Consumer Cyclical
7.6%
Energy
3.4%
Basic Materials
3.4%
Communication Services
3.1%
Consumer Defensive
2.9%
Real Estate
2.2%